JPMorgan Chase & Co. boosted its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 66.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 183,419 shares of the company's stock after buying an additional 73,395 shares during the period. JPMorgan Chase & Co. owned approximately 0.66% of ZimVie worth $2,911,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of ZIMV. Quarry LP grew its position in shares of ZimVie by 337.8% during the 2nd quarter. Quarry LP now owns 1,655 shares of the company's stock worth $30,000 after buying an additional 1,277 shares during the period. SG Americas Securities LLC acquired a new position in ZimVie during the third quarter valued at approximately $152,000. The Manufacturers Life Insurance Company bought a new stake in ZimVie in the second quarter valued at approximately $191,000. Principal Financial Group Inc. bought a new stake in ZimVie in the third quarter valued at approximately $275,000. Finally, Truist Financial Corp acquired a new stake in ZimVie in the second quarter worth $411,000. 95.63% of the stock is owned by institutional investors.
ZimVie Trading Up 1.7 %
Shares of ZIMV stock traded up $0.24 on Monday, hitting $14.29. The stock had a trading volume of 113,247 shares, compared to its average volume of 111,599. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a twelve month low of $13.01 and a twelve month high of $22.40. The company has a fifty day moving average price of $13.96 and a two-hundred day moving average price of $15.89. The firm has a market cap of $394.40 million, a P/E ratio of -1.09 and a beta of 2.11.
About ZimVie
(
Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
See Also
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
